Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELIGLUSTAT vs ELTROMBOPAG: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELIGLUSTAT vs ELTROMBOPAG: Safety Overview

Metric ELIGLUSTAT ELTROMBOPAG
Total FAERS Reports 1,368 5,473
Deaths Reported 18 1,434
Death Rate 1.3% 26.2%
Hospitalizations 173 2,066
Average Patient Age 48.6 yrs 55.3 yrs
% Female Patients 57.1% 53.5%
FDA Approval Date Aug 17, 2022 N/A
Manufacturer Genzyme Corporation N/A
Route ORAL N/A
Marketing Status Prescription None